Learn how PROTAC small molecule drugs are redefining cancer therapy by degrading, not just inhibiting, oncogenic proteins. Explore the PROTAC mechanism, their role in expanding the druggable cancer proteome, and their potential to overcome resistance in precision oncology.
- admin@condrug.com
- Mon - Sat: 8.00 am - 7.00 pm
We develop solutions for your clinical data needs